ACCC Recognizes Ethan Basch on Symptom Monitoring in Oncology
In Partnership With
Ethan Basch, MD, MSc, recently received the Clinical Research Award from the Association of Community Cancer Centers during the 2019 National Oncology Conference. Basch explains the importance of receiving this award in light of his work around patient-reported outcomes for symptom monitoring in oncology.
Ethan Basch, MD, MSc, director, Cancer Outcomes Research Program, and Richard M. Goldberg Distinguished Professor in Medical Oncology, UNC Lineberger Comprehensive Cancer Center, recently received the Clinical Research Award from the Association of Community Cancer Centers (ACCC) during the 2019 National Oncology Conference. Basch explains the importance of receiving this award in light of his work around patient-reported outcomes for symptom monitoring in oncology.
The idea of completing a questionnaire for symptom monitoring was not thought of by providers 15 years ago, says Basch. Today, more providers are monitoring patients, communicating with patients, and catching symptoms early. These concepts have now come into the forefront of how providers coordinate, manage, and navigate care.
Acalabrutinib/Obinutuzumab Shows Improved PFS in Treatment-Naive CLL
April 10th 2024In an interview with Targeted Oncology, Jeff Sharman, MD, discussed the results of the ELEVATE-TN trial of acalabrutinib with or without obinutuzumab at 74.5 months of follow-up among patients with chronic lymphocytic leukemia.
Read More
